Therapeutic possibilities of topical corticosteroids in modern clinical practice

Over the past decade, dermatological practice has seen an increase in the number of patients suffering from skin and subcutaneous tissue diseases. Annually, 6.4-6.9 million new cases of this group of diseases are registered, which encourages the constant search for new drugs and the continuous improvement of methods and schemes of application of proven drugs. Topical corticosteroids, despite more than 65 years of history of use in the treatment of patients with steroid-sensitive dermatoses, have not lost their relevance. At present, they have no therapeutic alternative in terms of speed of onset and anti-inflammatory activity, so they are essential in the treatment of many skin pathologies. One of the trends in modern pharmacology is not so much the production of new active molecules of TCS or their modifications, as the creation of new pharmacological forms of known molecules - micronized, nanonized, which give the drug the most important property -increased bioavailability. This advanced technology is actively used in the production of domestic topical drugs of Akriderm lines, which make a major contribution to the program of import substitution and drug availability for the population. The optimal combination of ingredients of the foundation of these drugs complements and potentiates the therapeutic effect of steroid. For more than 30 years in clinical practice, a combination of 0.05% betamethasone dipropionate, 0.1% gentamicin sulfate and 1% clotrimazole (Triderm, Akriderm GK) is used. Many years of positive clinical experience of dermatologists using this fixed combination proves the validity of its use in many clinical situations when bacterial and fungal infection is involved. An open randomized comparative study conducted by Russian dermatologists on the efficacy and safety of Akriderm GK (cream) and Triderm (cream) in the complex treatment of eczema showed similar profiles of high clinical efficacy and safety of both drugs.

1. Pomerantsev O.N., Potekaev N.N. The incidence of skin and sjbcjtaneojs fat diseases as a sociomedical problem. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2013;(6):4-6. (In Rjss.) Available at: https://www.mediasphera.rj/issjes/klinicheskaya-dermatologiya-i-venerologiya/2013/6/downloads/rj/031997-2849201361.

2. Wolff K., Goldsmith L.A., Katz S.I., Gilchrest B.A., Paller A.S., Leffell D.J. et al. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York: McGraw-Hill; 2008.

3. Akovbyan VA. Compositional preparations for external treat-ment: the advantages are obviojs. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology.2003;1(4):50-53. (In Rjss.)

4. Schafer-Korting M., Kleuser B., Ahmed M., Holtje H.D., Korting H.C. Gljcocorticoids for hjman skin: new aspects of mechanism of acfction. Skin Parmacol Physiol. 2005;18:103-114. doi: 10.1159/000084907.

5. Kleymenova I.A., Esenin S.A. History of creation and improvement of topical steroids. Dermatologiya. Prilozhenie k zhurnalu Concilium Medicum = Dermatology. Appendix to the Journal Concilium Medicum. 2011;(3):14-16. (In Russ.) Available at: https://elibrary.ru/item.asp?id=21289270.

6. Tadicherla S., Ross K., Shenefelt P.D., Fenske N.A. Topical corticosteroids in dermatology. J Drugs Dermatol. 2009;8(12):1093-1105. Available at: https://pubmed.ncbi.nlm.nih.gov/20027937/.

7. Matushevskaya E.V., Svirshchevskaya E.V. Drug micronization technique: new possibilities of topical corticosteroids in dermatology. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2017;1:43-48. (In Russ.) doi: 10.17116/klinder-ma201716143-48.

8. Ustinov M.V., Chaplygin A.V. Micronization and other ways to improve the efficiency and safety of topical drugs in dermatology. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2019;18(4):418-426. (In Russ.) doi: 10.17116/klinder-ma201918041418.

9. Kochergin N.G., Petrunin D.D. The current view on the problem of the choice of medications for external therapy. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2011;9(6):84-92. (In Russ.) Available at: https://elibrary.ru/item.asp?id=19011271.

10. Aravijskaya E.R., Sokolovsky E.V., Bakhtina S.M., Pchelintsev M.V. Role of vehicle in topical steroids: optimal composition and mode of action. Vestnik dermatologii i venerologii = Herald of Dermatology and Venereology. 2010;(2):64-70. Available at: https://elibrary.ru/item.asp?id=15152036.

11. Brazzini B., Pimpinelli N. New and established corticosteroids in dermatology:clinical pharmacology and therapeutic use. Am J Clin Dermatol. 2002;3(1):47-58. doi: 10.2165/00128071-200203010-00005.

12. Williams R.E. The Antibacterial-Corticosteroid Combination. What is its role in atopic dermatitis? Am J Clin Dermatol. 2000;1(4):211-215. doi: 10.2165/00128071-200001040-00002.

13. Lvov A.N. Propaedeutic principles of the use of a combination topical therapy in dermatoses caused by a combination of factors. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2016;(1):78-84. (In Russ.) doi: 10.17116/klinder-ma201615178-84.

14. Olisova O.Yu., Belousova T.A., Kail-Goriachkina M.V. The strategy and tactics of treatment of patients with infectious-inflammatory diseases of the skin. Dermatologiya. Prilozhenie k zhurnalu Concilium Medicum = Dermatology. Appendix to the Journal Concilium Medicum. 2017;(1):42-47. (In Russ.) Available at: https://elibrary.ru/item.asp?id=30267809.

15. Burtseva G.N., Sergeev V.Y., Sergeev A.Y. Linking the microbiological and clinicall variation in modern acne therapy. Immunopatologiya, allergologiya, infektologiya = International Journal of Immunopathology, Allergology, Infectology. 2014;(1):63-70. (In Russ.) Available at: https://elibrary.ru/item.asp?id=22504469.

16. Nenasheva N.M. Features of topical therapy for atopic dermatitis complicated by infection. RMZH = RMJ. 2015;(12):1-7. (In Russ.) Available at: https://www.rmj.ru/articles/dermatologiya/Osobennosti_mestnoy_narughnoy_terapii_osloghnennogo_infekciey_atopicheskogo_dermatita/.

17. Ustinov M.V. Empirical therapy of inflammatory skin lesions of large folds. RMZH = RMJ. 2016;(14):945-948. (In Russ.) Available at: https://www.rmj.ru/articles/dermatologiya/Empiricheskaya_terapiya_vospalitelynyh_poragheniy_koghi_krupnyh_skladok/

18. Kotrekhova L.P. Diagnostics and rational therapy of dermatoses of combined etiology. Dermatologiya. Prilozhenie k zhurnalu Concilium Medicum = Dermatology. Appendix to the Journal Concilium Medicum. 2010;(4):6-11. (In Russ.) Available at: https://elibrary.ru/item.asp?id=21280626.

19. Matushevskaya E.V., Shakurov I.G., Khismatulina Z.R. Effectiveness and tolerance of Akriderm preparations in dermatovenereologic practice. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2008;6(2):1-4. (In Russ.) Available at: https://elibrary.ru/item.asp?id=11576955.

20. Kasikhina E.I., Glazko I.I., Riabchikova M.D. PROBLEMS RELated to mixed infections: solutions and features of pathogenesis. Klinicheskaya derma-tologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2014;12(4):56-60. (In Russ.) Available at: https://www.mediasphera.ru/issues/klinicheskaya-dermatologiya-i-venerologiya/2014/4/031997-28492014410.

21. Torshina I.E. Topical therapy of infected corticosteroid-sensitive dermatoses. Vestnik dermatologii i venerologii Herald of Dermatology and Venereology. 2015;(5):102-108. (In Russ.) Available at:

22. Svirshchevskaya E.V., Matushevskaya E.V., Chudakov D.B., Matushevskaya Yu.I. The role of infection in the pathogenesis of allergodermatoses. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2015;(2):4-10. (In Russ.) doi: 10.17116/klinder-ma20151424-10.

23. Filimonkova N.N., Bakhlykova Y.A. A combined topical therapy of chronic dermatoses Vestnik dermatologii i venerologii = Herald of Dermatology and Venereology. 2015;(3):147-152. (In Russ.) doi: 10.25208/0042-4609-2015-91-3-147-152.

24. Khardikova S.A. Efficacy and tolerability of various forms of akriderm gk in routine dermatological practice. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2016;(5):55-61. (In Russ.) doi: 10.17116/klinder-ma201615555-61.

25. Khaldin A.A., Zhukova O.V. Open randomized controlled trial to study the effectiveness and safety of domestic (Russian) versus foreign multicomponent topical preparations for the treatment of eczema. Klinicheskaya der-matologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2019;18,(3):1-11. (In Russ.) doi: 10.17116/klinder-ma2019180311.